$31.96
-0.27-0.84%
Last update: Oct 29, 4:42 PM
Cogent Biosciences Inc (COGT) Stock Price, Quote, News & History
COGTNASDAQ
FDA accepts Cogent Biosciences' NDA for bezuclastinib in NonAdvSM. PDUFA date set for Dec 30, 2026. COGT stock rises on the news.
You can purchase shares of Cogent Biosciences (NASDAQ:COGT) through any online brokerage.
Other companies in Cogent Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Cogent Biosciences has a consensus price target of $37.67.
The stock price for Cogent Biosciences (NASDAQ: COGT) is $31.96 last updated October 29, 2026 at 4:42 PM EDT.
There are no upcoming dividends for Cogent Biosciences.
Cogent Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Cogent Biosciences.
Cogent Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its...
